Axial3D is significantly more solvent these days, having completed an $18.2 million investment round with support from new and existing financiers.

The latest funding came from Axial3D’s first round investors Techstart, Innovation Ulster Limited, Clarendon, and U.S. and Northern Ireland business Angels. Three new strategic investors also participated in the round: Whiterock, Innovate UK, and 57 Stars, the latter of which is now the company’s largest shareholder with its $10 million contribution. 

“We are delighted to have completed this investment round, which will enable us to accelerate our mission of making patient-specific surgery routine globally,” Axial3D CEO Roger Johnston said. “Our market-fundamental patented technology platform empowers medical device companies, medical imaging companies, and hospitals to standardize the use of precise, patient-specific 3D data that transforms their offerings for patients. Our AI technology has the power to impact millions of patients globally across patient specific applications in robotics, planning and patient specific device workflows.”

The new investors believe Axial3D is ideally positioned to lead the change to scalable, patient-specific solutions.

“Axial3D’s technology that creates patient-specific 3D imaging has already shown potential in the medtech space,” said Bernie McGuire, 57 Stars’ managing director and IC member. “We are excited to support their ongoing technology application expansion and look forward to seeing the impact their innovations will make in advancing personalized healthcare. This is the latest deal out of our long-standing Northern Ireland investment program, which has now committed over $50 million, and a prime example of our investment thesis of finding compelling opportunities at the intersection of healthcare and technology.”  

Whiterock Director Neil McCabe highlighted Axial3D’s potential to reshape healthcare with its technology. “Axial3D’s technology addresses a critical need in healthcare—enabling scalability in personalized care. We’re proud to join this journey, supporting a company that is paving the way for more accessible and precise surgical solutions worldwide.”

Axial3D turns DICOM images into detailed, actionable 3D data through its patented machine learning and artificial intelligence technology. Its easy-to-use cloud platform makes it possible to scale patient-specific care, empowering medical device companies and hospitals to deliver truly personalized surgical solutions. The company is based in Belfast, Ireland.